Neurocrine Biosciences | Işletme Karı

Operating Profit Değişiklik Tarih
AbbVie USD 3.2B 914M 2023-12
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Agios Pharmaceuticals USD -106277000 5.38M 2023-12
ALKERMES USD 43.85M 195.34M 2023-09
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amgen USD 1.27B 819M 2023-12
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Cytokinetics USD -127418000 5.15M 2023-12
Dynavax Technologies USD -8491000 13.61M 2023-12
Exelixis USD -17583000 95.43M 2023-09
Gilead Sciences USD 1.61B 1.01B 2023-12
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Incyte USD 187.27M 27.44M 2023-12
Intra Cellular Therapies USD -34097000 4.38M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Repligen USD -13563000 18.37M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Teva Pharmaceutical Industries USD 355M 1B 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Neurocrine Biosciences Işletme Karı - Akım değerleri, tarihsel veriler, tahminler, istatistikler, grafikler ve ekonomik takvim - Apr 2024.